SANTHERA PHARMACEUTICALS HOLDING AG CHF0.1 (POST CONS)SANTHERA PHARMACEUTICALS HOLDING AG CHF0.1 (POST CONS)SANTHERA PHARMACEUTICALS HOLDING AG CHF0.1 (POST CONS)

SANTHERA PHARMACEUTICALS HOLDING AG CHF0.1 (POST CONS)

No trades
See on Supercharts

0QN1 fundamentals

SANTHERA PHARMACEUTICALS HOLDING AG CHF0.1 (POST CONS) financial statements, including revenue, expenses, profit, and loss

The total revenue of 0QN1 for the last semiannual is 14.11 M CHF, and it's 85.81% lower compared to the previous semiannual. The net income of H1 24 is -15.26 M CHF.

Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: CHF
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth